Novadoz Pharmaceuticals glycopyrrolate oral solution recalled for failed purity specifications
Novadoz Pharmaceuticals is recalling specific lots of glycopyrrolate oral solution (1 mg/5 mL) because the medication failed quality testing for impurities and degradation. The affected lots may not meet safety and effectiveness standards. Three lots are involved, with expiration dates between April and May 2027.
From the FDA notice · Read the official notice ↗
What to do
- Check your glycopyrrolate bottle for lot number CB2505159A, CB2505160A, or CB2505161A
- Do not use the medication if it matches one of these lots
- Contact your pharmacist or doctor for a replacement or alternative medication
- Return the recalled medication to your pharmacy
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc., Piscataway, NJ 08854, Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854, NDC 72205-070-72
- Sold in
- Nationwide
- Made for
- All ages (0 months and older)
Details
- Units affected
- N/A
- Illnesses reported
- None reported
- Manufactured in
- 20 Duke Rd Ste A, N/A, Piscataway, NJ, United States
- Classification
- Class III
- Recall number
- D-0300-2026
In the FDA's words
- Description
- Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc., Piscataway, NJ 08854, Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854, NDC 72205-070-72 Failed Impurities/Degradation Specifications Lot # CB2505159A, CB2505160A, Exp Date: 04/2027; Lot # CB2505161A, Exp Date: 05/2027 Distribution: US Nationwide. Affected quantity: N/A
- Hazard
- Failed Impurities/Degradation Specifications